Pier Capital, LLC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 226 filers reported holding TG THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.

Quarter-by-quarter ownership
Pier Capital, LLC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,283,047
-43.6%
392,709
+67.6%
0.53%
-36.6%
Q2 2023$5,820,459
+65.8%
234,318
+0.4%
0.84%
+56.7%
Q1 2023$3,511,419
-67.7%
233,472
-16.8%
0.53%
-51.1%
Q2 2021$10,880,000
-10.9%
280,486
+10.7%
1.09%
-5.7%
Q1 2021$12,208,000
+62.5%
253,271
+75.4%
1.16%
+45.5%
Q4 2020$7,512,000
+4.4%
144,414
-46.3%
0.80%
-24.4%
Q3 2020$7,193,000268,8041.05%
Other shareholders
TG THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
M28 Capital Management LP 726,200$3,086,0003.46%
Paradigm Biocapital Advisors LP 1,964,709$8,350,0001.66%
683 Capital Management, LLC 3,300,000$14,025,0000.99%
MAVERICK CAPITAL LTD 6,747,549$28,677,0000.71%
Antara Capital LP 1,500,000$6,375,0000.27%
Parkwood LLC 47,168$1,375,0000.24%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,677,500$11,379,0000.24%
PURA VIDA INVESTMENTS, LLC 950,813$4,041,0000.24%
OCCUDO QUANTITATIVE STRATEGIES LP 567,576$2,412,0000.20%
Antara Capital LP 900,000$3,825,0000.16%
View complete list of TG THERAPEUTICS INC shareholders